Little Green Pharma Ltd

ASX:LGP.AX

0.115 (AUD) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) AUD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q2
Revenue 12.5456.27210.75.359.164.583.6613.6613.2321.6163.7710.5511.4880.7440.7160.3580.2220.1110.0270.013
Cost of Revenue 9.0743.7176.5832.8945.3251.9911.421.420.0070.0071.2420.2630.8470.4230.2040.1020.1340.0670.0480.007
Gross Profit 3.4712.5554.1162.4563.8342.5892.2412.2413.2251.6092.5290.2880.6410.3210.5120.2560.0870.044-0.0210.007
Gross Profit Ratio 0.2770.4070.3850.4590.4190.5650.6120.6120.9980.9960.6710.5230.4310.4310.7150.7150.3940.394-0.790.5
Reseach & Development Expenses 2.5911.2962.1861.0934.4082.2041.351.351.2640.6320.5160.2510.5840.2920.4210.210.150.0750.2230.111
General & Administrative Expenses 1.2431.2432.3292.3292.4242.4243.4833.4830.9950.9950.7630.680.8960.8961.2961.2960.9470.9470.8260.826
Selling & Marketing Expenses 0.7170.7170.760.760.9960.9960.9890.9890.7650.7650.290.3640.4880.4880.240.240.2660.2660.0570.057
SG&A 5.4942.7477.3463.6738.464.235.3415.3414.0952.4223.3641.0443.5921.7964.1522.0763.1281.5641.9961.016
Other Expenses 000000001.10600-0.4500000000
Operating Expenses 8.0853.4529.5322.81712.8686.0666.3576.3574.2549.2543.880.8464.1762.2244.5732.8343.2781.632.2191.179
Operating Income -4.614-0.905-5.416-0.546-9.034-3.045-3.959-3.959-1.46-0.486-1.351-2.247-3.535-1.468-4.061-2.03-3.191-1.595-2.241-0.99
Operating Income Ratio -0.368-0.144-0.506-0.102-0.986-0.665-1.081-1.081-0.452-0.301-0.358-4.078-2.376-1.973-5.671-5.671-14.4-14.4-83.247-73.564
Total Other Income Expenses Net 1.37-0.1350.8260.015-0.061-0.702-0.33-0.3323.6911.3520.345-0.082-0.275-0.438-1.444-0.7220.0180.009-0.105-0.183
Income Before Tax -3.244-1.04-4.59-0.531-9.095-3.748-4.289-4.28922.2310.866-1.006-2.329-3.81-1.905-5.505-2.753-3.172-1.586-2.346-1.173
Income Before Tax Ratio -0.259-0.166-0.429-0.099-0.993-0.818-1.172-1.1726.8776.723-0.267-4.227-2.561-2.561-7.688-7.688-14.317-14.317-87.154-87.151
Income Tax Expense -1.1640-3.5290-1.6000-1.8890-1.490.08200-000000
Net Income -2.08-1.04-1.061-0.531-7.495-3.748-4.289-4.28924.11910.8660.484-2.411-3.81-1.905-5.505-2.753-3.172-1.586-2.346-1.173
Net Income Ratio -0.166-0.166-0.099-0.099-0.818-0.818-1.172-1.1727.4626.7230.128-4.375-2.561-2.561-7.688-7.688-14.317-14.317-87.154-87.151
EPS -0.007-0.004-0.004-0.002-0.031-0.016-0.018-0.0180.150.0610.003-0.01-0.029-0.01-0.041-0.039-0.024-0.023-0.018-0.017
EPS Diluted -0.007-0.004-0.004-0.002-0.031-0.016-0.018-0.0180.150.0610.003-0.01-0.029-0.01-0.041-0.039-0.024-0.023-0.018-0.017
EBITDA -3.097-0.191-3.1240.557-8.342-2.699-3.496-3.496-1.021-0.368-1.104-2.2-3.32-1.427-3.895-1.948-3.131-1.571-2.206-0.973
EBITDA Ratio -0.247-0.03-0.2920.104-0.911-0.589-0.955-0.955-0.316-0.228-0.293-3.994-2.231-1.918-5.44-5.44-14.131-14.176-81.957-72.275